• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.鉴定卡他莫拉菌表面抗原作为慢性阻塞性肺疾病中人血清抗体反应的靶点
Infect Immun. 2005 Jun;73(6):3471-8. doi: 10.1128/IAI.73.6.3471-3478.2005.
2
Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中针对卡他莫拉菌的黏膜抗体反应的抗原特异性
Infect Immun. 2005 Dec;73(12):8161-6. doi: 10.1128/IAI.73.12.8161-8166.2005.
3
Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者对卡他莫拉菌外膜蛋白G1b的人血清及黏膜抗体反应
FEMS Immunol Med Microbiol. 2006 Feb;46(1):139-46. doi: 10.1111/j.1574-695X.2005.00020.x.
4
Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后对卡他莫拉菌的全身和黏膜抗体反应。
J Infect Dis. 2002 Mar 1;185(5):632-40. doi: 10.1086/339174. Epub 2002 Feb 5.
5
Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.卡他莫拉菌免疫球蛋白D结合外膜蛋白与普遍存在的表面蛋白A1和A2的血清学反应比较。
Infect Immun. 2006 Nov;74(11):6377-86. doi: 10.1128/IAI.00702-06. Epub 2006 Sep 11.
6
Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children.幼儿对卡他莫拉菌特定外膜蛋白的黏膜免疫反应。
Pediatr Infect Dis J. 2003 Mar;22(3):256-62. doi: 10.1097/01.inf.0000054827.86683.bd.
7
Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen.支气管扩张症患者中卡他莫拉菌(布兰汉菌)外膜蛋白(OMP)的血清抗体:鉴定OMP B1为重要抗原。
Infect Immun. 1995 Apr;63(4):1516-20. doi: 10.1128/iai.63.4.1516-1520.1995.
8
Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.利用卡他莫拉菌脂寡糖突变体鉴定人血清抗体识别的特定寡糖表位。
Infect Immun. 2009 Oct;77(10):4548-58. doi: 10.1128/IAI.00294-09. Epub 2009 Aug 3.
9
Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.儿童鼻咽部定植和急性中耳炎后对卡他莫拉菌蛋白OMP CD、OppA、Msp22、Hag和PilA2的血清抗体反应。
Vaccine. 2015 Oct 26;33(43):5809-5814. doi: 10.1016/j.vaccine.2015.09.023. Epub 2015 Sep 21.
10
Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.卡他莫拉菌外膜蛋白CD的抗原结构及人体免疫反应分析
Infect Immun. 1999 Sep;67(9):4578-85. doi: 10.1128/IAI.67.9.4578-4585.1999.

引用本文的文献

1
Otitis media: recent advances in otitis media vaccine development and model systems.中耳炎:中耳炎疫苗研发及模型系统的最新进展
Front Microbiol. 2024 Jan 24;15:1345027. doi: 10.3389/fmicb.2024.1345027. eCollection 2024.
2
The Direct Anti-Virulence but Not Bactericidal Activity of Human Neutrophil Elastase against .人中性粒细胞弹性蛋白酶对 的直接抗病毒作用而非杀菌活性。
Int J Mol Sci. 2023 Apr 1;24(7):6607. doi: 10.3390/ijms24076607.
3
Antibacterial Fusion Proteins Enhance Killing.抗菌融合蛋白增强杀伤作用。
Front Immunol. 2020 Sep 2;11:2122. doi: 10.3389/fimmu.2020.02122. eCollection 2020.
4
Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets.三聚体自转运黏附素的免疫原性及其作为疫苗靶标的潜力。
Med Microbiol Immunol. 2020 Jun;209(3):243-263. doi: 10.1007/s00430-019-00649-y. Epub 2019 Dec 1.
5
Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.卡他莫拉菌在慢性阻塞性肺疾病中的持续存在与 Hag/MID 黏附素的调节。
J Infect Dis. 2019 Apr 16;219(9):1448-1455. doi: 10.1093/infdis/jiy680.
6
A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.用于预防中耳炎和 COPD 加重的卡他莫拉菌疫苗:当前进展和挑战的更新。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2322-2331. doi: 10.1080/21645515.2017.1356951.
7
Potential impact of a Moraxella catarrhalis vaccine in COPD.莫拉氏菌疫苗对 COPD 的潜在影响。
Vaccine. 2019 Sep 3;37(37):5551-5558. doi: 10.1016/j.vaccine.2016.12.066. Epub 2017 Feb 6.
8
Vaccine targets against Moraxella catarrhalis.针对卡他莫拉菌的疫苗靶点。
Expert Opin Ther Targets. 2016;20(1):19-33. doi: 10.1517/14728222.2015.1081686. Epub 2015 Aug 26.
9
Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.儿童鼻咽部定植和急性中耳炎后对卡他莫拉菌蛋白OMP CD、OppA、Msp22、Hag和PilA2的血清抗体反应。
Vaccine. 2015 Oct 26;33(43):5809-5814. doi: 10.1016/j.vaccine.2015.09.023. Epub 2015 Sep 21.
10
Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.人肺泡巨噬细胞吞噬功能障碍与慢性阻塞性肺疾病严重程度的关系。
J Infect Dis. 2013 Dec 15;208(12):2036-45. doi: 10.1093/infdis/jit400. Epub 2013 Aug 1.

本文引用的文献

1
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.慢性阻塞性肺疾病中的卡他莫拉菌:疾病负担与免疫反应
Am J Respir Crit Care Med. 2005 Jul 15;172(2):195-9. doi: 10.1164/rccm.200412-1747OC. Epub 2005 Apr 1.
2
Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults.健康成年人中针对卡他莫拉菌外膜蛋白的唾液抗体。
Infect Immun. 2003 Dec;71(12):6793-8. doi: 10.1128/IAI.71.12.6793-6798.2003.
3
The bacteriology of chronic bronchitis.慢性支气管炎的细菌学
Lancet. 1953 Sep 12;265(6785):534-7. doi: 10.1016/s0140-6736(53)90274-8.
4
Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children.幼儿对卡他莫拉菌特定外膜蛋白的黏膜免疫反应。
Pediatr Infect Dis J. 2003 Mar;22(3):256-62. doi: 10.1097/01.inf.0000054827.86683.bd.
5
Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease.慢性阻塞性肺疾病成人患者对卡他莫拉菌外膜蛋白CD的免疫反应
Infect Immun. 2003 Mar;71(3):1288-94. doi: 10.1128/IAI.71.3.1288-1294.2003.
6
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.新型细菌菌株与慢性阻塞性肺疾病的急性加重
N Engl J Med. 2002 Aug 15;347(7):465-71. doi: 10.1056/NEJMoa012561.
7
Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后对卡他莫拉菌的全身和黏膜抗体反应。
J Infect Dis. 2002 Mar 1;185(5):632-40. doi: 10.1086/339174. Epub 2002 Feb 5.
8
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.慢性阻塞性肺疾病诊断、管理和预防全球策略。美国国立心肺血液研究所/世界卫生组织慢性阻塞性肺疾病全球倡议(GOLD)研讨会总结。
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76. doi: 10.1164/ajrccm.163.5.2101039.
9
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.2000年慢性阻塞性肺疾病中的细菌感染:最新综述
Clin Microbiol Rev. 2001 Apr;14(2):336-63. doi: 10.1128/CMR.14.2.336-363.2001.
10
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.稳定期慢性支气管炎患者气道细菌载量与气道炎症标志物之间的关联
Am J Med. 2000 Sep;109(4):288-95. doi: 10.1016/s0002-9343(00)00507-6.

鉴定卡他莫拉菌表面抗原作为慢性阻塞性肺疾病中人血清抗体反应的靶点

Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.

作者信息

Murphy Timothy F, Brauer Aimee L, Aebi Christoph, Sethi Sanjay

机构信息

VA Western New York Healthcare System, Medical Research 151, 3495 Bailey Avenue, Buffalo, NY 14215, USA.

出版信息

Infect Immun. 2005 Jun;73(6):3471-8. doi: 10.1128/IAI.73.6.3471-3478.2005.

DOI:10.1128/IAI.73.6.3471-3478.2005
PMID:15908376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1111810/
Abstract

Moraxella catarrhalis is an important respiratory tract pathogen, causing otitis media in children and lower respiratory tract infections in adults with chronic obstructive pulmonary disease (COPD). Adults with COPD make antibody responses to M. catarrhalis following infection, but little is known about the identity of the antigens to which these antibodies are directed. In this study, 12 serum samples obtained from adults with COPD who had cleared M. catarrhalis from the respiratory tract following infection and who had developed new serum immunoglobulin G (IgG) to their infecting strain were subjected to a series of assays to identify the antigens to which potentially protective antibodies were directed. Sera were adsorbed with intact bacterial cells, and antibodies were eluted from the surfaces of the bacteria. Analysis by flow cytometry established that adsorption and elution effectively detected antibodies specifically directed to surface-exposed epitopes. Immunoblot assays of adsorbed and eluted serum fractions were performed with purified outer membranes and purified lipooligosaccharide of homologous infecting strains and with a series of mutants deficient in expression of individual outer membrane proteins (OMPs). While heterogeneity in antibody responses among individuals was observed, five major OMPs, UspA1, UspA2, Hag, TbpB, and OMP CD, were identified as targets of antibodies to surface epitopes in the majority of adults with COPD who cleared the organism. These results have important implications in understanding human immune responses to M. catarrhalis and in elucidating the elements of a protective immune response.

摘要

卡他莫拉菌是一种重要的呼吸道病原体,可导致儿童中耳炎以及慢性阻塞性肺疾病(COPD)成人患者的下呼吸道感染。COPD成人患者在感染卡他莫拉菌后会产生抗体反应,但对于这些抗体所针对的抗原的具体情况却知之甚少。在本研究中,从呼吸道已清除卡他莫拉菌且针对感染菌株产生了新的血清免疫球蛋白G(IgG)的COPD成人患者中获取了12份血清样本,对其进行了一系列检测,以确定潜在保护性抗体所针对的抗原。血清用完整细菌细胞吸附,抗体从细菌表面洗脱。通过流式细胞术分析确定,吸附和洗脱有效地检测到了特异性针对表面暴露表位的抗体。用同源感染菌株的纯化外膜和纯化脂寡糖以及一系列单个外膜蛋白(OMP)表达缺陷的突变体对吸附和洗脱后的血清组分进行免疫印迹分析。虽然观察到个体间抗体反应存在异质性,但在大多数清除该病原体的COPD成人患者中,五种主要的OMP,即UspA1、UspA2、Hag、TbpB和OMP CD,被确定为针对表面表位抗体的靶点。这些结果对于理解人类对卡他莫拉菌的免疫反应以及阐明保护性免疫反应的要素具有重要意义。